| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Ipilimumab (Yervoy) and the TGN1412 catastrophe. | Immunobiology | 2011 | 1.53 |
| 2 | Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy). | Pharmacol Res | 2012 | 0.81 |
| 3 | Intentional coinfection of patients with HCV infection using avian infection bursal disease virus. | Hepatology | 2002 | 0.77 |
| 4 | T cells survey the stability of the self: a testable hypothesis on the homeostatic role of TCR-MHC interactions. | Int Arch Allergy Immunol | 2007 | 0.76 |
| 5 | Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering? | BMC Cancer | 2010 | 0.76 |
| 6 | Micromolar A and B blood group active trisaccharides abolish human complement haemolytic activity assayed by erythrocytes. | Int Arch Allergy Immunol | 2003 | 0.75 |